MarketInOut Stock Screener Log In | Sign Up
 

Conexeu Sciences Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 09/09/2026 16:00
Conexeu Sciences Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization125.23 mln
Float15.56 mln

Relative Strength

1 / 100
Severely lagging

Debt / Equity

0.00
Debt-free

ROE

-56.46
Deeply negative

Dividend Yield

0.00%
No dividend

DPS

0.00
No dividend

Payout Ratio

0%
No payout

Business Description

Conexeu Sciences Inc. is a Reno, Nevada-based company founded in 2022 that creates collagen-based scaffold products designed to support tissue repair and regeneration across medical and aesthetic applications. Their core offerings include a collagen extracellular matrix platform and an investigational collagen gel aimed at helping the body rebuild tissue while reducing unwanted inflammation or scarring. These products are being developed as natural alternatives to traditional fillers and implants for uses such as wound care, facial rejuvenation, and body contouring, with regulatory clearance still pending for several applications.

Key Fundamentals

EPS-0.35
ROE-56.46
ROIC-279
ROA-51.16
EBITDA, mln-4.01
EV / EBITDA-47.18
EV / EBIT-46.97

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -24.02% 1 / 100   
1 Month -38.65% 3 / 100   
2 Months -73.52% 3 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us